A citation-based method for searching scientific literature

Frank L J Visseren, François Mach, Yvo M Smulders, David Carballo, Konstantinos C Koskinas, Maria Bäck, Athanase Benetos, Alessandro Biffi, José-Manuel Boavida, Davide Capodanno, Bernard Cosyns, Carolyn Crawford, Constantinos H Davos, Ileana Desormais, Emanuele Di Angelantonio, Oscar H Franco, Sigrun Halvorsen, F D Richard Hobbs, Monika Hollander, Ewa A Jankowska, Matthias Michal, Simona Sacco, Naveed Sattar, Lale Tokgozoglu, Serena Tonstad, Konstantinos P Tsioufis, Ineke van Dis, Isabelle C van Gelder, Christoph Wanner, Bryan Williams. Eur J Prev Cardiol 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tight glycemic control may increase regenerative potential of myocardium during acute infarction.
Raffaele Marfella, Ferdinando Carlo Sasso, Federico Cacciapuoti, Michele Portoghese, Maria Rosaria Rizzo, Mario Siniscalchi, Ornella Carbonara, Franca Ferraraccio, Michele Torella, Antonello Petrella,[...]. J Clin Endocrinol Metab 2012
41
33

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
33

Dapagliflozin in Patients with Chronic Kidney Disease.
Hiddo J L Heerspink, Bergur V Stefánsson, Ricardo Correa-Rotter, Glenn M Chertow, Tom Greene, Fan-Fan Hou, Johannes F E Mann, John J V McMurray, Magnus Lindberg, Peter Rossing,[...]. N Engl J Med 2020
560
33


Effectiveness of aldosterone blockade in patients with diabetic nephropathy.
Atsuhisa Sato, Koichi Hayashi, Mitsuhide Naruse, Takao Saruta. Hypertension 2003
334
33

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.
E J Lewis, L G Hunsicker, W R Clarke, T Berl, M A Pohl, J B Lewis, E Ritz, R C Atkins, R Rohde, I Raz. N Engl J Med 2001
33


A new equation to estimate glomerular filtration rate.
Andrew S Levey, Lesley A Stevens, Christopher H Schmid, Yaping Lucy Zhang, Alejandro F Castro, Harold I Feldman, John W Kusek, Paul Eggers, Frederick Van Lente, Tom Greene,[...]. Ann Intern Med 2009
33


Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.
B M Brenner, M E Cooper, D de Zeeuw, W F Keane, W E Mitch, H H Parving, G Remuzzi, S M Snapinn, Z Zhang, S Shahinfar. N Engl J Med 2001
33

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse. N Engl J Med 2017
486
33

Management of diabetes mellitus in patients with chronic kidney disease.
Allison J Hahr, Mark E Molitch. Clin Diabetes Endocrinol 2015
41
33

Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis.
K Esmeijer, Olaf M Dekkers, Johan W de Fijter, Friedo W Dekker, Ellen K Hoogeveen. Sci Rep 2019
15
33

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.
Hiddo J L Heerspink, Avraham Karasik, Marcus Thuresson, Cheli Melzer-Cohen, Gabriel Chodick, Kamlesh Khunti, John P H Wilding, Luis Alberto Garcia Rodriguez, Lucia Cea-Soriano, Shun Kohsaka,[...]. Lancet Diabetes Endocrinol 2020
92
33

Multidisciplinary coordinated care for Type 2 diabetes: A qualitative analysis of patient perspectives.
Seth A Berkowitz, Stephanie A Eisenstat, Lily S Barnard, Deborah J Wexler. Prim Care Diabetes 2018
13
33


A cost analysis of intensified vs conventional multifactorial therapy in individuals with type 2 diabetes: a post hoc analysis of the Steno-2 study.
Joachim Gæde, Jens Oellgaard, Rikke Ibsen, Peter Gæde, Emil Nørtoft, Hans-Henrik Parving, Jakob Kjellberg, Oluf Pedersen. Diabetologia 2019
9
33

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
George L Bakris, Rajiv Agarwal, Stefan D Anker, Bertram Pitt, Luis M Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph,[...]. N Engl J Med 2020
188
33

Prediction of prevalence of chronic kidney disease in diabetic patients in countries of the European Union up to 2025.
Alexander Kainz, Milan Hronsky, Vianda S Stel, Kitty J Jager, Angelika Geroldinger, Daniela Dunkler, Georg Heinze, Giovanni Tripepi, Rainer Oberbauer. Nephrol Dial Transplant 2015
35
33

Comprehensive Care for People With Diabetic Kidney Disease.
Koyal Jain, Amy K Mottl. Diabetes Spectr 2015
3
33

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis.
Gemma Currie, Alison H M Taylor, Toshiro Fujita, Hiroshi Ohtsu, Morten Lindhardt, Peter Rossing, Lene Boesby, Nicola C Edwards, Charles J Ferro, Jonathan N Townend,[...]. BMC Nephrol 2016
66
33

A Unifying Approach for GFR Estimation: Recommendations of the NKF-ASN Task Force on Reassessing the Inclusion of Race in Diagnosing Kidney Disease.
Cynthia Delgado, Mukta Baweja, Deidra C Crews, Nwamaka D Eneanya, Crystal A Gadegbeku, Lesley A Inker, Mallika L Mendu, W Greg Miller, Marva M Moxey-Mims, Glenda V Roberts,[...]. Am J Kidney Dis 2021
6
33

Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury.
Peter Kolkhof, Martina Delbeck, Axel Kretschmer, Wolfram Steinke, Elke Hartmann, Lars Bärfacker, Frank Eitner, Barbara Albrecht-Küpper, Stefan Schäfer. J Cardiovasc Pharmacol 2014
144
33

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Bertram Pitt, Gerasimos Filippatos, Rajiv Agarwal, Stefan D Anker, George L Bakris, Peter Rossing, Amer Joseph, Peter Kolkhof, Christina Nowack, Patrick Schloemer,[...]. N Engl J Med 2021
17
33

Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention.
Julio Alejandro Lamprea-Montealegre, Michael G Shlipak, Michelle M Estrella. Heart 2021
1
100

Update on the treatment of type 2 diabetes mellitus.
Juan José Marín-Peñalver, Iciar Martín-Timón, Cristina Sevillano-Collantes, Francisco Javier Del Cañizo-Gómez. World J Diabetes 2016
180
33

CKD Awareness Among US Adults by Future Risk of Kidney Failure.
Chi D Chu, Charles E McCulloch, Tanushree Banerjee, Meda E Pavkov, Nilka R Burrows, Brenda W Gillespie, Rajiv Saran, Michael G Shlipak, Neil R Powe, Delphine S Tuot. Am J Kidney Dis 2020
17
33

A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers.
Jackson Musuuza, Bryn L Sutherland, Suleyman Kurter, Prakash Balasubramanian, Christie M Bartels, Meghan B Brennan. J Vasc Surg 2020
28
33

Effectiveness of chronic care models for the management of type 2 diabetes mellitus in Europe: a systematic review and meta-analysis.
Brenda W C Bongaerts, Karsten Müssig, Johan Wens, Caroline Lang, Peter Schwarz, Michael Roden, Wolfgang Rathmann. BMJ Open 2017
26
33

SGLT2 Inhibitors in Diabetic Kidney Disease.
Sophia Zoungas, Ian H de Boer. Clin J Am Soc Nephrol 2021
3
33

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.
Bertram Pitt, Lars Kober, Piotr Ponikowski, Mihai Gheorghiade, Gerasimos Filippatos, Henry Krum, Christina Nowack, Peter Kolkhof, So-Young Kim, Faiez Zannad. Eur Heart J 2013
247
33

Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease.
Neil A Smart, Gudrun Dieberg, Maleeka Ladhani, Thomas Titus. Cochrane Database Syst Rev 2014
92
33

Finerenone-A New Frontier in Renin-Angiotensin-Aldosterone System Inhibition in Diabetic Kidney Disease.
Vikas S Sridhar, Hongyan Liu, David Z I Cherney. Am J Kidney Dis 2021
2
50

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.
Kunihiro Matsushita, Marije van der Velde, Brad C Astor, Mark Woodward, Andrew S Levey, Paul E de Jong, Josef Coresh, Ron T Gansevoort. Lancet 2010
33

Glycemic Monitoring and Management in Advanced Chronic Kidney Disease.
Rodolfo J Galindo, Roy W Beck, Maria F Scioscia, Guillermo E Umpierrez, Katherine R Tuttle. Endocr Rev 2020
13
33

GLP-1 Receptor Agonists in Diabetic Kidney Disease.
Erin D Michos, Katherine R Tuttle. Clin J Am Soc Nephrol 2021
1
100

Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes.
Kelvin Lingjet Tran, Young In Park, Shalin Pandya, Navin John Muliyil, Brandon David Jensen, Kovin Huynh, Quang T Nguyen. Am Health Drug Benefits 2017
50
33

Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes.
Ferdinando Carlo Sasso, Luca Rinaldi, Nadia Lascar, Aldo Marrone, Pia Clara Pafundi, Luigi Elio Adinolfi, Raffaele Marfella. J Diabetes Res 2018
39
33

Diabetic kidney disease: a report from an ADA Consensus Conference.
Katherine R Tuttle, George L Bakris, Rudolf W Bilous, Jane L Chiang, Ian H de Boer, Jordi Goldstein-Fuchs, Irl B Hirsch, Kamyar Kalantar-Zadeh, Andrew S Narva, Sankar D Navaneethan,[...]. Diabetes Care 2014
443
33

Multidisciplinary care: experience of patients with complex needs.
Della Maneze, Sarah Dennis, Huei-Yang Chen, Jane Taggart, Sanjyot Vagholkar, Jeremy Bunker, Siaw Teng Liaw. Aust J Prim Health 2014
12
33

Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.
Joseph A Vassalotti, Robert Centor, Barbara J Turner, Raquel C Greer, Michael Choi, Thomas D Sequist. Am J Med 2016
91
33

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
33


Systematic review of multidisciplinary interventions in heart failure.
R Holland, J Battersby, I Harvey, E Lenaghan, J Smith, L Hay. Heart 2005
218
33


Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
George L Bakris, Rajiv Agarwal, Juliana C Chan, Mark E Cooper, Ron T Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E Schmieder, Christina Nowack,[...]. JAMA 2015
291
33

Continuous glucose monitoring in diabetes patients with chronic kidney disease on dialysis: a meta-analysis.
Fei Wang, Dan Wang, Xi-Ling Lyu, Xiao-Ming Sun, Bin-Hong Duan. Minerva Endocrinol 2020
2
50



The myeloid mineralocorticoid receptor controls inflammatory and fibrotic responses after renal injury via macrophage interleukin-4 receptor signaling.
Jonatan Barrera-Chimal, Gabriel R Estrela, Sebastian M Lechner, Sébastien Giraud, Soumaya El Moghrabi, Shiem Kaaki, Peter Kolkhof, Thierry Hauet, Frédéric Jaisser. Kidney Int 2018
46
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.